Definition

  • Practices that ensure injections are given in a manner that does not harm the recipient, does not expose the provider to unnecessary risk of blood-borne infections and does not result in any waste that is dangerous for the community (WHO 2010, updated IPAC 2022)

Importance in Pediatrics

  • Children receive multiple injections (UIP schedule, therapeutic injections, RBSK interventions)
  • Higher vulnerability due to immature immune system and repeated exposure in hospitals/OPDs
  • Unsafe injections contribute to 1.67 million HBV, 0.34 million HCV and 0.16 million HIV infections annually worldwide (WHO estimates)
  • In India: ~20–30% of injections still unsafe; major source of iatrogenic transmission of BBVs in children

Risks of Unsafe Injections

  • Recipient: Transmission of HBV (most common), HCV, HIV, abscess, sepsis, paralysis (inappropriate site)
  • Provider: Needle-stick injury (NSI) → seroconversion risk
  • Community: Reuse of syringes, open burning → environmental hazard

Core Components (The “Bundle”)

1. Right Patient, Right Drug, Right Dose, Right Route, Right Time, Right Documentation

2. Aseptic Technique

  • Hand hygiene (alcohol-based hand rub or soap-water) before and after procedure
  • Use of sterile single-use syringe and needle (auto-disable syringes preferred in UIP)
  • Skin preparation with 70% isopropyl alcohol swab (allow to dry)
  • No recapping of needles

3. Single-Use Policy

  • Never reuse syringes/needles
  • Auto-disable (AD) syringes mandatory for all immunizations under UIP/U-WIN
  • Prefilled syringes/ampoules opened only for single patient

4. Safe Sharps Disposal

  • Immediate disposal into puncture-proof, leak-proof sharps container (blue/white bin) at point of use
  • Fill to ¾ capacity → seal and transport as per Biomedical Waste Management Rules 2016 (amended 2018/2022)
  • Treatment: Autoclaving/shredding/incineration at Common Biomedical Waste Treatment Facility (CBWTF)

5. Post-Exposure Prophylaxis (PEP) Protocol

  • Immediate wound wash with soap-water
  • Report NSI → baseline testing of source and exposed person
  • PEP for HIV (within 2 hours), HBV (if unvaccinated), HCV (monitoring)

Pediatric-Specific Considerations

  • Use shortest possible needle (25–27G for IM in infants); vastus lateralis preferred site <12 months
  • Distraction techniques, sucrose analgesia, proper positioning to reduce pain
  • Vaccine-specific: Cold chain maintenance + AD syringes for all UIP antigens
  • Integration with RBSK (DEIC injections), SNCU/pediatric wards, school health
  • AB PM-JAY/ABDM linkage: Record every injection in digital health record for traceability

National Guidelines & Implementation (2026)

  • MoHFW Injection Safety Guidelines 2022 (updated under NTEP/IPC)
  • Mandatory training for all healthcare workers (ANM, ASHA, doctors) under NHM
  • Surveillance: Monthly reporting of NSI and unsafe injection events through HMIS/ABDM
  • Convergence: UIP (U-WIN AD syringes), RBSK, RKSK, NTEP (TB injections)
  • Monitoring: District-level Injection Safety Committees; audits using WHO checklist

Key Performance Indicators

  • 100% use of AD syringes in immunization
  • Zero recapping of needles
  • 100% sharps disposal in designated containers
  • NSI incidence <1 per 1000 injections
  • 100% PEP compliance within 2 hours